Regulation
FDA approves Artivion’s AMDS device PMA
Artivion received FDA PMA clearance for its AMDS Hybrid Prosthesis device, indicated for treatment of acute DeBakey Type I aortic dissections with clinical or radiographic malperfusion. The approval permits commercial distribution in the US market.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network